Who makes Lactulose crystals 30 g?

Lactulose crystals 30 g is developed by Fresenius Kabi.

What development phase is Lactulose crystals 30 g in?

Lactulose crystals 30 g is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Lactulose crystals 30 g

Fresenius Kabi · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Lactulose crystals 30 g
Also known as	Laevolac crystals 30 g
Sponsor	Fresenius Kabi
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lactulose crystals 30 g CI brief — competitive landscape report
Lactulose crystals 30 g updates RSS · CI watch RSS
Fresenius Kabi portfolio CI